Nanotechnology in artificial organ development and its application in diagnosis methodology in baroreflex sensitivity of patients with hypertension

• Autorzy: Yambe T. , Yoshizawa S. , Sugita N. , Tanaka A. , Imachi K.
• Języki publikacji: EN

Abstrakty

EN

Space in the human body is so limited that nanotechnology and micromachining technology are the important for the development of the internal artificial organs. Based on the nanotechnology, various kinds of artificial organ development have been performed in Tohoku University including artificial myocardium, artificial heart, rotary blood pump, artificial esophagus, and artificial sphincter. Furthermore, automatic control algorithm for the artificial heart and assisted circulation was applied to the invention of the new diagnosis methodology for the baroreflex sensitivity of the patients with hypertension. Successful clinical application of this new invention was performed. The technical application to the large range is expectable in artificial internal-organs development.

Słowa kluczowe

EN

nanotechnology; artificial myocardium; rotary blood pump; baroreflex sensitivity; hypertension

PL

nanotechnologia; sztuczny mięsień sercowy; przepływ krwi; pompa rotacyjna; nadciśnienie

• Wydawca: Nałęcz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences ; Elsevier
• Czasopismo: Biocybernetics and Biomedical Engineering
• Rocznik: 2007
• Tom: Vol. 27, no. 1-2
• Strony: 65--70
• Opis fizyczny: Bibliogr. 7 poz., rys., wykr.

Twórcy

autor

Yambe T.

autor

Yoshizawa S.

autor

Sugita N.

autor

Tanaka A.

autor

Imachi K.

• 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan,

Bibliografia

• 1. Watanabe M., Sekine K., Hori Y., Shiraishi Y, MaedaT., Honma D., Mryata G., Saijo Y, Yambe T.: Artificial esophagus with peristaltic movement. ASAIO J. 2005 Mar-Apr, 51 (2), 158-161.
• 2. Yambe T., Shiraishi Y, Yoshizawa M., Tanaka A., Abe K., Sato P., Matsuki H., Esashi M., Haga Y, Maruyama S., Takagi T., Luo Y, Okamoto E., Kubo Y, Osaka M., Nanka S., Saijo Y, Mibiki Y, Yamaguchi T., Shibata M., Nitta S.: Artificial myocardium with an artificial baroreflex system using nano technology. Biomed. Pharmacother. 2003 Oct, 57 Suppl. 1, 122-125.
• 3. Matsuzawa Y: The metabolic syndrome and adipocytokines. FEES Lett. 2006 May 22, 580(12), 2917-21. Epub. 2006 Apr 21. Review.
• 4. Beske S.D., Alvarez G.E., Ballard T.P., Davy K.P.: Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 2002 Feb., 282(2), H630-635.
• 5. Pikkujamsa S.M., Huikuri H.V., Airaksinen K.E., Rantala A.O., Kauma H., Lilja M., Savolainen M.J., Kesaniemi Y. A.: Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am. J. Hypertens. 1998 May, 11(5), 523-531.
• 6. Honzikova N., Novakova Z., Zavodna E., Paderova J., Lokaj P., Fiser B., Balcarkova P., Hrstkova H.: Baroreflex sensitivity in children, adolescents, and young adults with essential and white-coat hypertension. Klin. Padiatr. 2006 Jul-Aug, 218(4), 237-242.
• 7. Lipsitz L.A., Iloputaife I., Gagnon M., Kiely D.K., Serrador J.M.: Enhanced vasoreactivity and its response to antihypertensive therapy in hypertensive elderly women. Hypertension. 2006 Mar, 47(3), 377-383.